Fjarde AP Fonden Fourth Swedish National Pension Fund raised its stake in HCP, Inc. (NYSE:HCP) by 18.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 115,043 shares of the real estate investment trust’s stock after buying an additional 17,536 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in HCP were worth $3,677,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of HCP. Andra AP fonden increased its position in HCP by 17.0% in the second quarter. Andra AP fonden now owns 96,400 shares of the real estate investment trust’s stock valued at $3,081,000 after buying an additional 14,000 shares during the last quarter. Willingdon Wealth Management increased its position in HCP by 3.1% in the second quarter. Willingdon Wealth Management now owns 42,942 shares of the real estate investment trust’s stock valued at $1,372,000 after buying an additional 1,272 shares during the last quarter. Robeco Institutional Asset Management B.V. increased its position in HCP by 18.3% in the second quarter. Robeco Institutional Asset Management B.V. now owns 191,055 shares of the real estate investment trust’s stock valued at $6,106,000 after buying an additional 29,591 shares during the last quarter. Essex Financial Services Inc. acquired a new position in HCP during the second quarter valued at $350,000. Finally, Mastrapasqua Asset Management Inc. increased its position in HCP by 11.3% in the second quarter. Mastrapasqua Asset Management Inc. now owns 12,975 shares of the real estate investment trust’s stock valued at $415,000 after buying an additional 1,320 shares during the last quarter. Institutional investors and hedge funds own 89.74% of the company’s stock.

Shares of HCP, Inc. (HCP) opened at 29.51 on Wednesday. The company has a market capitalization of $13.84 billion, a P/E ratio of 20.12 and a beta of 0.37. The company has a 50-day moving average price of $30.50 and a 200-day moving average price of $31.19. HCP, Inc. has a 12 month low of $27.61 and a 12 month high of $40.43.

HCP (NYSE:HCP) last issued its earnings results on Tuesday, August 1st. The real estate investment trust reported $0.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.01. HCP had a return on equity of 9.96% and a net margin of 32.16%. The firm had revenue of $458.90 million for the quarter, compared to analysts’ expectations of $456.29 million. During the same quarter last year, the firm earned $0.71 earnings per share. The firm’s revenue for the quarter was down 14.8% compared to the same quarter last year. On average, analysts forecast that HCP, Inc. will post $1.35 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, August 22nd. Investors of record on Monday, August 7th were issued a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a yield of 5.02%. The ex-dividend date of this dividend was Thursday, August 3rd. HCP’s payout ratio is currently 102.07%.

TRADEMARK VIOLATION WARNING: This piece was first posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/hcp-inc-hcp-stake-boosted-by-fjarde-ap-fonden-fourth-swedish-national-pension-fund/1531757.html.

Several research firms have weighed in on HCP. Stifel Nicolaus restated a “hold” rating and issued a $30.00 price target on shares of HCP in a research note on Tuesday, August 22nd. BidaskClub downgraded HCP from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Jefferies Group LLC restated a “hold” rating and issued a $33.00 price target on shares of HCP in a research note on Tuesday, July 25th. Goldman Sachs Group, Inc. (The) downgraded HCP from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $35.00 to $32.00 in a research note on Monday, July 24th. Finally, Zacks Investment Research downgraded HCP from a “hold” rating to a “sell” rating in a research note on Tuesday, July 18th. Three investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and three have issued a buy rating to the company’s stock. HCP currently has an average rating of “Hold” and a consensus price target of $32.70.

In related news, insider Thomas Klaritch sold 2,651 shares of HCP stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $31.53, for a total value of $83,586.03. Following the transaction, the insider now owns 176,830 shares in the company, valued at $5,575,449.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.22% of the stock is currently owned by company insiders.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.